This HTML5 document contains 68 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n15http://localhost/temp/predkladatel/
n16http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n13http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00216208%3A11130%2F09%3A6882%21RIV13-MSM-11130___/
n5http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n10http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n18http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n9http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n7http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00216208%3A11130%2F09%3A6882%21RIV13-MSM-11130___
rdf:type
n5:Vysledek skos:Concept
rdfs:seeAlso
http://www.ncbi.nlm.nih.gov/pubmed/19880844
dcterms:description
Anemia is associated with an increased risk of cardiovascular and renal events among patients with type 2 diabetes and chronic kidney disease. Although darbepoetin alfa can effectively increase hemoglobin levels, its effect on clinical outcomes in these patients has not been adequately tested. Anemia is associated with an increased risk of cardiovascular and renal events among patients with type 2 diabetes and chronic kidney disease. Although darbepoetin alfa can effectively increase hemoglobin levels, its effect on clinical outcomes in these patients has not been adequately tested.
dcterms:title
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
skos:prefLabel
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
skos:notation
RIV/00216208:11130/09:6882!RIV13-MSM-11130___
n3:aktivita
n4:I n4:N
n3:aktivity
I, N
n3:cisloPeriodika
21
n3:dodaniDat
n7:2013
n3:domaciTvurceVysledku
n16:1789880
n3:druhVysledku
n18:J
n3:duvernostUdaju
n10:S
n3:entitaPredkladatele
n13:predkladatel
n3:idSjednocenehoVysledku
301639
n3:idVysledku
RIV/00216208:11130/09:6882
n3:jazykVysledku
n14:eng
n3:klicovaSlova
stage renal-disease; erythropoiesis-stimulating agents; recombinant human erythropoietin; randomized-trials; cardiovascular-disease; hemodialysis-patients; anemia correction; clinical-trials; epoetin-alpha; risk-factor
n3:klicoveSlovo
n6:recombinant%20human%20erythropoietin n6:clinical-trials n6:randomized-trials n6:risk-factor n6:erythropoiesis-stimulating%20agents n6:epoetin-alpha n6:cardiovascular-disease n6:hemodialysis-patients n6:anemia%20correction n6:stage%20renal-disease
n3:kodStatuVydavatele
US - Spojené státy americké
n3:kontrolniKodProRIV
[16C922052C81]
n3:nazevZdroje
New England Journal of Medicine
n3:obor
n9:FE
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
804
n3:rokUplatneniVysledku
n7:2009
n3:svazekPeriodika
361
n3:tvurceVysledku
Chen, Chao-Yin Kirshenbaum, H. Solomon, Scott Eckardt, Kai-Uwe Magana, A. Ivanovich, Peter Parfrey, Patrick Kvapil, Milan Kramer, S. McGill, Janet Pfeffer, Marc Toto, Robert Zeeuw, Dick Parving, Hans-Henrik Cooper, Mark E Remuzzi, Giuseppe Feyzi, Jan Levey, Andrew Burdmann, Emmanuel McMurray, John Kewalramani, Reshma Singh, Ajay Lewis, Eldrin
n3:wos
000271898600007
s:issn
0028-4793
s:numberOfPages
14
n15:organizacniJednotka
11130